カテゴリー： 世界, 医療/バイオ, LP Information

世界の整形外科非ステロイド性抗炎症薬（NSAID）市場予測 2023年-2029年

【英語タイトル】Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC01078）・商品コード：LP23DC01078
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の整形外科非ステロイド性抗炎症薬（NSAID）市場」は、過去の販売実績から2022年の世界の整形外科非ステロイド性抗炎症薬（NSAID）の総販売量を検討し、2023年から2029年の予測される整形外科非ステロイド性抗炎症薬（NSAID）の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の整形外科非ステロイド性抗炎症薬（NSAID）の市場規模を掲載し、XXX百万米ドル規模の世界の整形外科非ステロイド性抗炎症薬（NSAID）市場の詳細な分析を提供します。本インサイトレポートは、世界の整形外科非ステロイド性抗炎症薬（NSAID）業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の整形外科非ステロイド性抗炎症薬（NSAID）市場における各社の独自のポジションをより深く理解するために、整形外科非ステロイド性抗炎症薬（NSAID）製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の整形外科非ステロイド性抗炎症薬（NSAID）市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。整形外科非ステロイド性抗炎症薬（NSAID）の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。整形外科非ステロイド性抗炎症薬（NSAID）の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。整形外科非ステロイド性抗炎症薬（NSAID）のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

整形外科非ステロイド性抗炎症薬（NSAID）の世界主要メーカーとしては、Merck、 Bayer、 JandJ、 GSK、 Septodont、 Roche、 PerioChip、 Sunstar、 Colgate-Palmolive、 DenMat、 Showa Yakuhin Kakoなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の整形外科非ステロイド性抗炎症薬（NSAID）市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では整形外科非ステロイド性抗炎症薬（NSAID）市場をセグメンテーションし、種類別 (注射式、経口式、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：注射式、経口式、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の整形外科非ステロイド性抗炎症薬（NSAID）市場の10年間の市場状況・展望は？
・世界および地域別に見た整形外科非ステロイド性抗炎症薬（NSAID）市場成長の要因は何か？
・整形外科非ステロイド性抗炎症薬（NSAID）の市場機会はエンドマーケットの規模によってどのように変化するのか？
・整形外科非ステロイド性抗炎症薬（NSAID）のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：整形外科非ステロイド性抗炎症薬（NSAID）の年間販売量2018-2029、地域別現状・将来分析
・整形外科非ステロイド性抗炎症薬（NSAID）の種類別セグメント：注射式、経口式、その他
・整形外科非ステロイド性抗炎症薬（NSAID）の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・整形外科非ステロイド性抗炎症薬（NSAID）の用途別セグメント：病院、診療所、その他
・整形外科非ステロイド性抗炎症薬（NSAID）の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の整形外科非ステロイド性抗炎症薬（NSAID）市場
・企業別のグローバル整形外科非ステロイド性抗炎症薬（NSAID）市場データ：2018-2023年の年間販売量、市場シェア
・企業別の整形外科非ステロイド性抗炎症薬（NSAID）の年間売上：2018-2023年の売上、市場シェア
・企業別の整形外科非ステロイド性抗炎症薬（NSAID）販売価格
・主要企業の整形外科非ステロイド性抗炎症薬（NSAID）生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

整形外科非ステロイド性抗炎症薬（NSAID）の地域別レビュー
・地域別の整形外科非ステロイド性抗炎症薬（NSAID）市場規模2018-2023：年間販売量、売上
・主要国別の整形外科非ステロイド性抗炎症薬（NSAID）市場規模2018-2023：年間販売量、売上
・南北アメリカの整形外科非ステロイド性抗炎症薬（NSAID）販売の成長
・アジア太平洋の整形外科非ステロイド性抗炎症薬（NSAID）販売の成長
・ヨーロッパの整形外科非ステロイド性抗炎症薬（NSAID）販売の成長
・中東・アフリカの整形外科非ステロイド性抗炎症薬（NSAID）販売の成長

南北アメリカ市場
・南北アメリカの国別の整形外科非ステロイド性抗炎症薬（NSAID）販売量、売上（2018-2023）
・南北アメリカの整形外科非ステロイド性抗炎症薬（NSAID）の種類別販売量
・南北アメリカの整形外科非ステロイド性抗炎症薬（NSAID）の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の整形外科非ステロイド性抗炎症薬（NSAID）販売量、売上（2018-2023）
・アジア太平洋の整形外科非ステロイド性抗炎症薬（NSAID）の種類別販売量
・アジア太平洋の整形外科非ステロイド性抗炎症薬（NSAID）の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の整形外科非ステロイド性抗炎症薬（NSAID）販売量、売上（2018-2023）
・ヨーロッパの整形外科非ステロイド性抗炎症薬（NSAID）の種類別販売量
・ヨーロッパの整形外科非ステロイド性抗炎症薬（NSAID）の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の整形外科非ステロイド性抗炎症薬（NSAID）販売量、売上（2018-2023）
・中東・アフリカの整形外科非ステロイド性抗炎症薬（NSAID）の種類別販売量
・中東・アフリカの整形外科非ステロイド性抗炎症薬（NSAID）の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・整形外科非ステロイド性抗炎症薬（NSAID）の製造コスト構造分析
・整形外科非ステロイド性抗炎症薬（NSAID）の製造プロセス分析
・整形外科非ステロイド性抗炎症薬（NSAID）の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・整形外科非ステロイド性抗炎症薬（NSAID）の主要なグローバル販売業者
・整形外科非ステロイド性抗炎症薬（NSAID）の主要なグローバル顧客

地域別の整形外科非ステロイド性抗炎症薬（NSAID）市場予測レビュー
・地域別の整形外科非ステロイド性抗炎症薬（NSAID）市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・整形外科非ステロイド性抗炎症薬（NSAID）の種類別市場規模予測
・整形外科非ステロイド性抗炎症薬（NSAID）の用途別市場規模予測

主要企業分析
Merck、 Bayer、 JandJ、 GSK、 Septodont、 Roche、 PerioChip、 Sunstar、 Colgate-Palmolive、 DenMat、 Showa Yakuhin Kako
・企業情報
・整形外科非ステロイド性抗炎症薬（NSAID）製品
・整形外科非ステロイド性抗炎症薬（NSAID）販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is projected to grow from US$ 224 million in 2022 to US$ 312.6 million in 2029; it is expected to grow at a CAGR of 4.9% from 2023 to 2029.
United States market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) players cover Merck, Bayer, JandJ, GSK, Septodont, Roche, PerioChip, Sunstar and Colgate-Palmolive, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Forecast” looks at past sales and reviews total world Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales in 2022, providing a comprehensive analysis by region and market sector of projected Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales for 2023 through 2029. With Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) industry.
This Insight Report provides a comprehensive analysis of the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).
This report presents a comprehensive overview, market shares, and growth opportunities of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injection Type
Oral Type
Others
Segmentation by application
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Sunstar
Colgate-Palmolive
DenMat
Showa Yakuhin Kako
Key Questions Addressed in this Report
What is the 10-year outlook for the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market?
What factors are driving Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market opportunities vary by end market size?
How does Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Country/Region, 2018, 2022 & 2029
2.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type
2.2.1 Injection Type
2.2.2 Oral Type
2.2.3 Others
2.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
2.3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2018-2023)
2.3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Price by Type (2018-2023)
2.4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application
2.5.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Market Share by Application (2018-2023)
2.5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Price by Application (2018-2023)
3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Company
3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Company
3.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Sales by Company (2018-2023)
3.1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Company (2018-2023)
3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Revenue by Company (2018-2023)
3.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Company (2018-2023)
3.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Company (2018-2023)
3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Price by Company
3.4 Key Manufacturers Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Location Distribution
3.4.2 Players Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Geographic Region
4.1 World Historic Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Geographic Region (2018-2023)
4.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country/Region (2018-2023)
4.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth
4.4 APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth
4.5 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth
4.6 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth
5 Americas
5.1 Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
5.1.1 Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2018-2023)
5.1.2 Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2018-2023)
5.2 Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
5.3 Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region
6.1.1 APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2018-2023)
6.1.2 APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2018-2023)
6.2 APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
6.3 APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Country
7.1.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2018-2023)
7.1.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2018-2023)
7.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
7.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Country
8.1.1 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2018-2023)
8.2 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type
8.3 Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
10.3 Manufacturing Process Analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
10.4 Industry Chain Structure of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Distributors
11.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Customer
12 World Forecast Review for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Geographic Region
12.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Region
12.1.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Region (2024-2029)
12.1.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Type
12.7 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.1.3 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.2.3 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 JandJ
13.3.1 JandJ Company Information
13.3.2 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.3.3 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 JandJ Main Business Overview
13.3.5 JandJ Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.4.3 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Septodont
13.5.1 Septodont Company Information
13.5.2 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.5.3 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Septodont Main Business Overview
13.5.5 Septodont Latest Developments
13.6 Roche
13.6.1 Roche Company Information
13.6.2 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.6.3 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Roche Main Business Overview
13.6.5 Roche Latest Developments
13.7 PerioChip
13.7.1 PerioChip Company Information
13.7.2 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.7.3 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 PerioChip Main Business Overview
13.7.5 PerioChip Latest Developments
13.8 Sunstar
13.8.1 Sunstar Company Information
13.8.2 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.8.3 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sunstar Main Business Overview
13.8.5 Sunstar Latest Developments
13.9 Colgate-Palmolive
13.9.1 Colgate-Palmolive Company Information
13.9.2 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.9.3 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Colgate-Palmolive Main Business Overview
13.9.5 Colgate-Palmolive Latest Developments
13.10 DenMat
13.10.1 DenMat Company Information
13.10.2 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.10.3 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 DenMat Main Business Overview
13.10.5 DenMat Latest Developments
13.11 Showa Yakuhin Kako
13.11.1 Showa Yakuhin Kako Company Information
13.11.2 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
13.11.3 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Showa Yakuhin Kako Main Business Overview
13.11.5 Showa Yakuhin Kako Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection Type
Table 4. Major Players of Oral Type
Table 5. Major Players of Others
Table 6. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2018-2023) & (K Units)
Table 7. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2018-2023)
Table 8. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2018-2023) & ($ million)
Table 9. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2018-2023)
Table 10. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2018-2023) & (K Units)
Table 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2018-2023)
Table 13. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2018-2023)
Table 14. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2018-2023)
Table 15. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Company (2018-2023) & (K Units)
Table 17. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Company (2018-2023)
Table 18. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Company (2018-2023)
Table 20. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Producing Area Distribution and Sales Area
Table 22. Players Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Products Offered
Table 23. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Geographic Region (2018-2023)
Table 28. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country/Region (2018-2023)
Table 32. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2018-2023) & (K Units)
Table 35. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2018-2023)
Table 36. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2018-2023)
Table 38. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2018-2023) & (K Units)
Table 39. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2018-2023) & (K Units)
Table 40. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2018-2023) & (K Units)
Table 41. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region (2018-2023)
Table 42. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2018-2023)
Table 44. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2018-2023) & (K Units)
Table 45. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2018-2023) & (K Units)
Table 46. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2018-2023) & (K Units)
Table 47. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2018-2023)
Table 48. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2018-2023)
Table 50. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2018-2023) & (K Units)
Table 51. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 59. Key Market Challenges & Risks of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 60. Key Industry Trends of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Table 61. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Distributors List
Table 64. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Customer List
Table 65. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Merck Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 80. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 81. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Merck Main Business
Table 83. Merck Latest Developments
Table 84. Bayer Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 86. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Bayer Main Business
Table 88. Bayer Latest Developments
Table 89. JandJ Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 90. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 91. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. JandJ Main Business
Table 93. JandJ Latest Developments
Table 94. GSK Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 95. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 96. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. GSK Main Business
Table 98. GSK Latest Developments
Table 99. Septodont Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 100. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 101. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Septodont Main Business
Table 103. Septodont Latest Developments
Table 104. Roche Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 105. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 106. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Roche Main Business
Table 108. Roche Latest Developments
Table 109. PerioChip Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 110. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 111. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. PerioChip Main Business
Table 113. PerioChip Latest Developments
Table 114. Sunstar Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 115. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 116. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Sunstar Main Business
Table 118. Sunstar Latest Developments
Table 119. Colgate-Palmolive Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 120. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 121. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Colgate-Palmolive Main Business
Table 123. Colgate-Palmolive Latest Developments
Table 124. DenMat Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 125. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 126. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. DenMat Main Business
Table 128. DenMat Latest Developments
Table 129. Showa Yakuhin Kako Basic Information, Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Manufacturing Base, Sales Area and Its Competitors
Table 130. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolios and Specifications
Table 131. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Showa Yakuhin Kako Main Business
Table 133. Showa Yakuhin Kako Latest Developments
List of Figures
Figure 1. Picture of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Figure 2. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection Type
Figure 10. Product Picture of Oral Type
Figure 11. Product Picture of Others
Figure 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type in 2022
Figure 13. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2018-2023)
Figure 14. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumed in Hospital
Figure 15. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Hospital (2018-2023) & (K Units)
Figure 16. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumed in Clinic
Figure 17. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Clinic (2018-2023) & (K Units)
Figure 18. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Consumed in Others
Figure 19. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market: Others (2018-2023) & (K Units)
Figure 20. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2022)
Figure 21. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application in 2022
Figure 22. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market by Company in 2022 (K Units)
Figure 23. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Company in 2022
Figure 24. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Company in 2022
Figure 26. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales 2018-2023 (K Units)
Figure 29. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 2018-2023 ($ Millions)
Figure 30. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales 2018-2023 (K Units)
Figure 31. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 2018-2023 ($ Millions)
Figure 32. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales 2018-2023 (K Units)
Figure 33. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue 2018-2023 ($ Millions)
Figure 36. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2022
Figure 37. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country in 2022
Figure 38. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2018-2023)
Figure 39. Americas Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2018-2023)
Figure 40. United States Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Region in 2022
Figure 45. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions in 2022
Figure 46. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2018-2023)
Figure 47. APAC Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2018-2023)
Figure 48. China Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2022
Figure 56. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country in 2022
Figure 57. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2018-2023)
Figure 58. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2018-2023)
Figure 59. Germany Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2018-2023)
Figure 68. Egypt Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in 2022
Figure 74. Manufacturing Process Analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Figure 75. Industry Chain Structure of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Figure 76. Channels of Distribution
Figure 77. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Forecast by Region (2024-2029)
Figure 78. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の整形外科非ステロイド性抗炎症薬（NSAID）市場予測 2023年-2029年] (コード：LP23DC01078)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の整形外科非ステロイド性抗炎症薬（NSAID）市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の疼痛管理用治療薬市場予測2023-2029：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他
  • 世界の慢性疲労症候群治療薬市場予測2023-2029：鎮痛剤・NSAID、抗うつ薬・抗精神病薬、抗菌薬・免疫調節薬
  • 世界の抗ミュラー管ホルモン（AMH）市場予測 2023年-2029年
  • 世界の抗HCV（C型肝炎ウイルス）迅速検査キット（金コロイド法）市場予測 2023年-2029年
  • 世界の陽電子放射マンモグラフィー（PEM）市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆